Regulation of neurotrophins
Disclosed are methods for regulating neurotrophin levels within a human body. The invention utilizes an implantable signal generator to deliver stimulation to neural tissue elements. Alternatively, an implantable pump may be utilized to delivery one or more drugs. The implanted device delivers treatment therapy to the neural tissue to thereby alter the level of neurotrophic factors such as BDNF expressed by the influenced neural tissue. A sensor may be used to detect various symptoms of a nervous system disorder. A microprocessor algorithm may then analyze the output from the sensor to regulate the treatment therapy delivered to the body. The invention describes a novel method to regulate the intrinsic levels of neurotrophins and may be used to treat patients with neurological and cognitive disorders.
1. A method for regulating the level of one or more neurotrophic factors in neural tissue of the cortex or sub-cortex to treat or alleviate a neurological disorder involving neuronal loss or damage, the method comprising:
delivering stimulation energy from a stimulation device to stimulate tissue of a neural circuit of the limbic system selected from the group consisting of the hippocampus, the formix, the mammillary body, the anterior thalamic nuclei, and the cingulate gyrus through an electrode to thereby increase or decrease the level of the one or more neurotrophic factors and treat or alleviate the neurological disorder.
2. The method as in claim 1 , further comprising selecting amplitude, width and frequency of the stimulation energy to be delivered by the electrode.
3. The method as in claim 1 , wherein deliverying stimulation energy comprises operating a signal generator to pulse electrical energy at a frequency between 2 Hertz and 1000 Hertz.
4. The method as in claim 3 , wherein the signal generator is operated to pulse at a pulse amplitude between 0.1 Volts to 10.0 Volts.
5. The method as in claim 4 , wherein the signal generator is operated to pulse at a pulse width between 30 microseconds and 150 microseconds.
6. The method as in claim 3 , wherein the signal generator is operated in a monopolar configuration.
7. The method as in claim 3 , wherein the signal generator is operated in a bipolar configuration.
8. The method as in claim 3 , wherein the signal generate is operated in a multipolar configuration.
9. The method as in claim 3 , wherein the signal generator is operated in a continuous mode.
10. The method as in claim 3 , where the signal generator is operated in a cyclical mode.
11. The method as in claim 1 , further comprising selecting between an open loop and a closed loop mode of operation.
12. The method as in claim 1 , wherein delivering stimulation energy comprises adjusting at least one parameter of the stimulation energy, the parameter being selected from the group consisting of amplitude, pulse width and frequency.
13. The method as in claim 1 , further comprising:
implanting at least one secondary electrode so that a secondary stimulation portion lies in communication with a portion of the body;
coupling the secondary electrode to the signal generator; and
operating the signal generator to stimulate the portion of the body.
14. The method as in claim 1 , further comprising:
implanting at least one catheter so that a discharge portion lies in communication with a second neural tissue of said body;
coupling the catheter to a pump; and
operating the pump to deliver drug to the second neural tissue to thereby alter the level of neurotrophin generated by the second neural tissue.